 | • レポートコード：QYR2104Z5464 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳卒中診断＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（虚血性脳卒中、出血性脳卒中）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳卒中診断＆治療の市場動向 ・企業の競争状況、市場シェア ・脳卒中診断＆治療の種類別市場規模（診断、治療） ・脳卒中診断＆治療の用途別市場規模（虚血性脳卒中、出血性脳卒中） ・脳卒中診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・脳卒中診断＆治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳卒中診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳卒中診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳卒中診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck） ・結論 |
Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced.
Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed in the global stroke diagnostics and therapeutics market.
Market Analysis and Insights: Global Stroke Diagnostics and Therapeutics Market
The global Stroke Diagnostics and Therapeutics market size is projected to reach US$ 31190 million by 2026, from US$ 22350 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stroke Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stroke Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stroke Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stroke Diagnostics and Therapeutics market.
Global Stroke Diagnostics and Therapeutics Scope and Market Size
Stroke Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stroke Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Ischemic Stroke
Haemorrhagic Stroke
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Stroke Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ischemic Stroke
1.3.3 Haemorrhagic Stroke
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stroke Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Stroke Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Stroke Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stroke Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Stroke Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Stroke Diagnostics and Therapeutics Industry Dynamic
2.3.1 Stroke Diagnostics and Therapeutics Market Trends
2.3.2 Stroke Diagnostics and Therapeutics Market Drivers
2.3.3 Stroke Diagnostics and Therapeutics Market Challenges
2.3.4 Stroke Diagnostics and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Stroke Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Stroke Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Stroke Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stroke Diagnostics and Therapeutics Revenue
3.4 Global Stroke Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Stroke Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Diagnostics and Therapeutics Revenue in 2020
3.5 Stroke Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Stroke Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Stroke Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Stroke Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)
5 Stroke Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Stroke Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Stroke Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Stroke Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Stroke Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Stroke Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Stroke Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Stroke Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Stroke Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Stroke Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Stroke Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Stroke Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stroke Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Stroke Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Stroke Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Stroke Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Stroke Diagnostics and Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Cordis
11.2.1 Cordis Company Details
11.2.2 Cordis Business Overview
11.2.3 Cordis Stroke Diagnostics and Therapeutics Introduction
11.2.4 Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Cordis Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Stroke Diagnostics and Therapeutics Introduction
11.3.4 Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Stroke Diagnostics and Therapeutics Introduction
11.4.4 Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Siemens Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Stroke Diagnostics and Therapeutics Introduction
11.5.4 Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Genentech Recent Development
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Stroke Diagnostics and Therapeutics Introduction
11.6.4 Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.6.5 Koninklijke Philips Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Stroke Diagnostics and Therapeutics Introduction
11.7.4 Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.7.5 Medtronic Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Stroke Diagnostics and Therapeutics Introduction
11.8.4 GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.8.5 GE Healthcare Recent Development
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Stroke Diagnostics and Therapeutics Introduction
11.9.4 Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.9.5 Stryker Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Stroke Diagnostics and Therapeutics Introduction
11.10.4 Merck Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Stroke Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Stroke Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Stroke Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Stroke Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Table 10. Stroke Diagnostics and Therapeutics Market Trends
Table 11. Stroke Diagnostics and Therapeutics Market Drivers
Table 12. Stroke Diagnostics and Therapeutics Market Challenges
Table 13. Stroke Diagnostics and Therapeutics Market Restraints
Table 14. Global Stroke Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Stroke Diagnostics and Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Stroke Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stroke Diagnostics and Therapeutics as of 2020)
Table 17. Ranking of Global Top Stroke Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Stroke Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stroke Diagnostics and Therapeutics Product Solution and Service
Table 21. Date of Enter into Stroke Diagnostics and Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Stroke Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Stroke Diagnostics and Therapeutics Product
Table 64. Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Cordis Company Details
Table 67. Cordis Business Overview
Table 68. Cordis Stroke Diagnostics and Therapeutics Product
Table 69. Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Cordis Recent Development
Table 71. Boston Scientific Company Details
Table 72. Boston Scientific Business Overview
Table 73. Boston Scientific Stroke Diagnostics and Therapeutics Product
Table 74. Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Boston Scientific Recent Development
Table 76. Siemens Company Details
Table 77. Siemens Business Overview
Table 78. Siemens Stroke Diagnostics and Therapeutics Product
Table 79. Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Siemens Recent Development
Table 81. Genentech Company Details
Table 82. Genentech Business Overview
Table 83. Genentech Stroke Diagnostics and Therapeutics Product
Table 84. Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. Koninklijke Philips Company Details
Table 87. Koninklijke Philips Business Overview
Table 88. Koninklijke Philips Stroke Diagnostics and Therapeutics Product
Table 89. Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Koninklijke Philips Recent Development
Table 91. Medtronic Company Details
Table 92. Medtronic Business Overview
Table 93. Medtronic Stroke Diagnostics and Therapeutics Product
Table 94. Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Medtronic Recent Development
Table 96. GE Healthcare Company Details
Table 97. GE Healthcare Business Overview
Table 98. GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 99. GE Healthcare Recent Development
Table 100. Stryker Company Details
Table 101. Stryker Business Overview
Table 102. Stryker Stroke Diagnostics and Therapeutics Product
Table 103. Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Stryker Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Stroke Diagnostics and Therapeutics Product
Table 108. Merck Revenue in Stroke Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Merck Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stroke Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Stroke Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Ischemic Stroke Case Studies
Figure 6. Haemorrhagic Stroke Case Studies
Figure 7. Stroke Diagnostics and Therapeutics Report Years Considered
Figure 8. Global Stroke Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Stroke Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Stroke Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Stroke Diagnostics and Therapeutics Market Share by Players in 2020
Figure 13. Global Top Stroke Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stroke Diagnostics and Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Stroke Diagnostics and Therapeutics Revenue in 2020
Figure 15. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Stroke Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Stroke Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Stroke Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Stroke Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Stroke Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Stroke Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Stroke Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Stroke Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Stroke Diagnostics and Therapeutics Market Share by Region (2016-2027)
Figure 37. China Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Stroke Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Stroke Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Stroke Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Stroke Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Stroke Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Stroke Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Stroke Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 57. Cordis Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 58. Boston Scientific Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 59. Siemens Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 60. Genentech Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 61. Koninklijke Philips Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 62. Medtronic Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 64. Stryker Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…- 世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 世界の虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Market Analysis and Insights: Global Ischemic S…
- 世界の虚血性脳卒中治療薬市場規模・現状・予測（2021年-2027年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年） According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected…